FDA Inspection 1229926 — Delpharm Dijon
The FDA completed an inspection of Delpharm Dijon on Nov 19, 2021 in Quetigny. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 19, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Quetigny (France)
Additional details
Mutual Recognition Agreement (MRA)